{"gene":"UCP2","run_date":"2026-04-28T21:43:00","timeline":{"discoveries":[{"year":1999,"finding":"Retinoids (retinoic acid) activate proton transport by UCP2 in a pH-dependent manner, demonstrated using yeast mitochondria expressing UCP2 by genetic manipulation; UCP2 proton conductance is positively regulated by retinoids and negatively regulated by nucleotides, analogous to UCP1 but with distinct pharmacology.","method":"In vitro proton transport assay in yeast mitochondria expressing recombinant UCP2; comparison with UCP1 and UCP3","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted activity in yeast expression system with direct transport measurements, orthogonal comparison across UCP family members","pmids":["10545094"],"is_preprint":false},{"year":2005,"finding":"SIRT1 represses UCP2 transcription by binding directly to the UCP2 promoter in pancreatic beta cells; reduced SIRT1 leads to elevated UCP2, blunted ATP production after glucose stimulation, and impaired insulin secretion; UCP2 knockdown rescues insulin secretion in SIRT1-deficient cells.","method":"ChIP (SIRT1 binding to UCP2 promoter), siRNA knockdown of SIRT1 and UCP2, glucose-stimulated insulin secretion assay, SIRT1 knockout mice","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, siRNA rescue, KO mice) in single high-citation study","pmids":["16366736"],"is_preprint":false},{"year":2006,"finding":"UCP2 mRNA translation is controlled by an upstream open reading frame (uORF) in its 5' UTR encoding a 36-amino-acid peptide; the 3' region of the uORF is the major determinant of translational inhibition, and silent single-base substitutions in this region significantly alter UCP2 translation.","method":"Reporter constructs with uORF mutations, in vitro translation assays","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 1 — mutagenesis of regulatory element with direct functional readout, single study","pmids":["16845607"],"is_preprint":false},{"year":2004,"finding":"hnRNPK (heterogeneous nuclear ribonucleoprotein K) binds to the 3' UTR of ucp2 mRNA and associates with polysome-coated mitochondria; hnRNPK overexpression augments insulin-induced mitochondrial UCP2 protein levels without changing mRNA levels, indicating translational regulation.","method":"Yeast three-hybrid screen, co-immunoprecipitation, polysome fractionation, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — yeast three-hybrid plus polysome fractionation and functional protein quantification, single lab","pmids":["15485813"],"is_preprint":false},{"year":2011,"finding":"UCP2 prevents mitochondrial glucose oxidation in human pluripotent stem cells (hPSCs) and facilitates glycolysis via a substrate shunting mechanism; ectopic UCP2 expression perturbs the metabolic transition during differentiation and impairs differentiation potential.","method":"siRNA knockdown and ectopic overexpression of UCP2, oxygen consumption measurements, metabolic flux assays, differentiation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function with defined metabolic and differentiation readouts, multiple methods","pmids":["22085932"],"is_preprint":false},{"year":2014,"finding":"UCP2 functions as a mitochondrial metabolite transporter: when reconstituted in lipid vesicles, UCP2 catalyzes exchange of malate, oxaloacetate, and aspartate for phosphate plus a proton; by exporting C4 compounds out of mitochondria, UCP2 limits glucose oxidation and enhances glutaminolysis.","method":"Reconstitution of UCP2 in lipid vesicles with direct transport assay; metabolomics of siUCP2-HepG2 cells; mitochondrial membrane potential and ATP:ADP measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro reconstitution of transport activity plus cellular validation with multiple metabolic readouts","pmids":["24395786"],"is_preprint":false},{"year":2020,"finding":"UCP2 catalyzes aspartate efflux from mitochondria in KRAS-mutant pancreatic cancer cells, connecting mitochondrial glutamine metabolism to cytosolic NADPH production; UCP2 silencing decreases glutaminolysis, lowers NADPH/NADP+ and glutathione ratios, increases ROS, and suppresses KRASmut PDAC cell growth in vitro and in vivo.","method":"UCP2 siRNA knockdown, metabolic flux assays, NADPH/NADP+ measurement, ROS detection, xenograft tumor models","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 — mechanistic link to transport activity established in PMID 24395786, confirmed here with in vivo tumor models and multiple metabolic readouts","pmids":["33230296"],"is_preprint":false},{"year":2012,"finding":"Glutathionylation of UCP2 deactivates proton leak; chemical induction of glutathionylation (diamide) selectively inhibits proton leak through UCP2 in drug-resistant leukemia (Mx2) cells, disabling chemoresistance; UCP2 knockdown reduces state 4 (proton leak-dependent) respiration by ~62%.","method":"Diamide-induced glutathionylation, proton leak respiration assay, UCP2 knockdown, cell viability with chemotherapeutics","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — direct manipulation of PTM (glutathionylation) with functional respiratory readout, single lab","pmids":["23069211"],"is_preprint":false},{"year":2008,"finding":"UCP2 is expressed at significantly higher levels in pancreatic alpha-cells than beta-cells; reducing UCP2 activity in alpha-cells increases mitochondrial membrane potential and ATP synthesis efficiency, leads to reduced glucagon secretion at low glucose, and increases alpha-cell sensitivity to death stimuli.","method":"UCP2−/− mice, mitochondrial membrane potential measurement, ATP/O ratio, glucagon secretion assays, cell death assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — knockout mouse with multiple orthogonal readouts (bioenergetics, secretion, survival), replicated across in vitro and in vivo","pmids":["18701716"],"is_preprint":false},{"year":2013,"finding":"Alpha-cell-specific UCP2 deletion impairs glucagon secretion in response to hypoglycemia; UCP2-deleted alpha-cells accumulate intracellular ROS due to enhanced mitochondrial coupling, which directly perturbs stimulus-secretion coupling; exogenous ROS application mimics UCP2 deletion effects on glucagon secretion.","method":"Alpha-cell-specific UCP2 knockout mice, ROS measurement, glucagon secretion assay, genipin pharmacological inhibition of UCP2, human islet studies","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — conditional KO plus pharmacological inhibitor plus ROS rescue experiment, multiple orthogonal methods","pmids":["23434936"],"is_preprint":false},{"year":2007,"finding":"UCP2 controls macrophage activation by modulating mitochondrial ROS production and MAPK signaling; UCP2-deficient macrophages show increased IL-1β and nitric oxide production, leading to accelerated autoimmune diabetes in a streptozotocin model.","method":"UCP2 knockout mice, macrophage cytokine assays, NO measurement, insulitis scoring","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with defined cellular mechanism (ROS/MAPK), multiple inflammatory readouts","pmids":["18006654"],"is_preprint":false},{"year":2009,"finding":"Ghrelin-induced neuroprotection of nigrostriatal dopamine neurons is dependent on UCP2-mediated alterations in mitochondrial respiration, ROS production, and biogenesis; ghrelin receptor (GHSR) activation in substantia nigra requires UCP2 for its mitochondrial redox mechanism of protection.","method":"Ghrelin/GHSR knockout mice, MPTP neurotoxin model, selective GHSR reactivation in catecholaminergic neurons, mitochondrial respiration and ROS assays, UCP2-dependent rescue experiments","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (GHSR KO + UCP2 dependence) with mitochondrial functional readouts in vivo","pmids":["19906954"],"is_preprint":false},{"year":2019,"finding":"Microglial UCP2 mediates HFD-induced changes in mitochondrial dynamics and microglia activation; selective microglial deletion of Ucp2 prevents mitochondrial dynamic changes, microglia activation, and hypothalamic inflammation, protecting mice from diet-induced obesity with decreased feeding and increased energy expenditure.","method":"Conditional microglial Ucp2 knockout, mitochondrial dynamics imaging, hypothalamic inflammation markers, synaptic input analysis, POMC neuron activation","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with mechanistic readouts linking mitochondrial function to hypothalamic circuit activity and obesity","pmids":["31495690"],"is_preprint":false},{"year":2021,"finding":"Microglial UCP2 regulates phasic elimination of spine synapses in ventral hippocampus; conditional Ucp2 ablation from microglia impairs synapse phagocytosis, causes ROS accumulation and lysosome-lipid droplet complex formation, resulting in hippocampal circuit dysfunction and altered anxiety-like behavior.","method":"Conditional microglial Ucp2 KO, confocal imaging of microglia-synapse contacts, ROS assay, electrophysiology, behavioral testing","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with mechanistic cellular and circuit-level readouts","pmids":["33879866"],"is_preprint":false},{"year":2008,"finding":"UCP2 upregulation in NASH liver induces mitochondrial proton leak, measured directly as increased proton conductance in isolated mitochondria; this correlates with increased H2O2 production and decreased ATP content, reducing the liver's ability to respond to acute energy demands such as ischemia-reperfusion.","method":"Isolated mitochondria proton leak measurement, H2O2 synthesis assay, GSH/GSSG ratio, ATP homeostasis in NASH rat model and human biopsy samples","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2 — direct mitochondrial bioenergetic measurements in both rat model and human tissue, single lab","pmids":["18308829"],"is_preprint":false},{"year":2017,"finding":"UCP2 controls mitochondrial ROS and MAPK signaling in macrophages through the FABP4-UCP2 axis; FABP4 deletion elevates intracellular free fatty acids and increases UCP2 expression, reducing ER stress, NLRP3 inflammasome activation, and IL-1β secretion; these effects are reversed by UCP2 silencing.","method":"FABP4/aP2 knockout and pharmacological inhibition, UCP2 siRNA, inflammasome activation assays, mitochondrial protein oxidation proteomics","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological manipulation with rescue by UCP2 silencing, multiple orthogonal mechanistic readouts","pmids":["27795298"],"is_preprint":false},{"year":2014,"finding":"UCP2 overexpression in cancer cells restores oxidative phosphorylation balance (reversing Warburg effect) through substrate routing (not membrane potential uncoupling), activates AMPK signaling, and downregulates HIF expression, repressing malignant phenotypes.","method":"UCP2 overexpression in cancer cell lines, Seahorse metabolic flux analysis, AMPK and HIF protein measurement, tumorigenesis assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple metabolic and signaling readouts, mechanistic distinction from uncoupling activity, single lab","pmids":["24853548"],"is_preprint":false},{"year":2022,"finding":"In endothelial cells, KLF2 directly binds the UCP2 promoter to upregulate its transcription in response to unidirectional shear stress; UCP2 suppresses endothelial inflammation through AMPK-mediated inhibition of FoxO1; EC-specific Ucp2 deletion promotes atherosclerosis, while AAV-mediated overexpression inhibits it.","method":"ChIP (KLF2 binding to UCP2 promoter), shear stress simulation, EC-specific Ucp2 KO mice, AAV-mediated overexpression, RNA-seq, AMPK/FoxO1 pathway analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — direct promoter binding (ChIP), conditional KO and overexpression in vivo, multiple pathway readouts","pmids":["35899624"],"is_preprint":false},{"year":2005,"finding":"UCP2 is recruited to hepatocyte mitochondria after LPS challenge; LPS increases UCP2 protein 3-fold (quantified by 3H-GTP binding sites), reduces mitochondrial membrane potential, and increases H2O2 production reversed by GDP (UCP2 inhibitor), indicating functional UCP2-mediated uncoupling in hepatocytes during infection.","method":"3H-GTP binding assay for UCP2 protein quantification, mitochondrial membrane potential (JC-1), H2O2 assay with GDP inhibition, real-time RT-PCR","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct quantification of functional UCP2 using radioligand binding plus GDP-sensitive H2O2 assay, single lab","pmids":["15694840"],"is_preprint":false},{"year":2012,"finding":"UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells; UCP2 overexpression reduces basal autophagy, establishing an anti-autophagic role for UCP2 through ROS control.","method":"Genipin pharmacological inhibition and siRNA knockdown of UCP2, ROS measurement, GAPDH nuclear translocation assay, autophagosome formation, LC3-II Western blot, UCP2 overexpression","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain/loss of function with defined mechanistic pathway, single lab","pmids":["23124112"],"is_preprint":false},{"year":2017,"finding":"UCP2 controls pancreas development through a ROS-AKT signaling pathway; Ucp2 knockout mice show increased PDX1+ progenitor cells and expanded alpha- and beta-cell mass, associated with increased NRF2 nuclear translocation and AKT phosphorylation; N-acetylcysteine administration rescued the pancreatic developmental phenotype.","method":"Ucp2 knockout mice, pancreas morphometry, ROS measurement, NRF2 nuclear translocation assay, pAKT Western blot, antioxidant rescue experiment","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — KO phenotype rescued by antioxidant treatment establishing ROS-AKT mechanism, multiple orthogonal readouts","pmids":["29079704"],"is_preprint":false},{"year":2019,"finding":"UCP2 deficiency increases colon tumorigenesis by promoting phospholipid synthesis and depleting NADPH for antioxidant defenses; UCP2 loss alters glycolytic pathways and increases oxidized glutathione levels, rendering colon cells more prone to malignant transformation.","method":"UCP2 KO in AOM/DSS and ApcMin/+ mouse cancer models, metabolomics (NADPH, glutathione oxidation, phospholipid), tumor histopathology","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — in vivo cancer models with defined metabolic mechanism, multiple orthogonal methods","pmids":["31461648"],"is_preprint":false},{"year":2022,"finding":"UCP2 acts as a metabolic oxygen sensor in cardiomyocytes; under moderate hypoxia, UCP2 increases acetyl-CoA levels and histone acetylation, promoting cardiomyocyte cell cycle activity; UCP2 knockout under hypoxia reduces cardiomyocyte cell cycle activity, increases DNA damage and fibrosis.","method":"UCP2 global KO mice under hypoxia, acetyl-CoA measurement, histone acetylation assay, chromatin modifier analysis, DNA damage markers, cardiomyocyte cell cycle analysis","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with mechanistic acetyl-CoA/histone acetylation readouts, single lab","pmids":["35771638"],"is_preprint":false},{"year":2002,"finding":"UCP2 is expressed in neurons of subcortical brain regions and is rapidly induced after brain lesions with an inverse relationship to caspase-3 activation; overexpression of UCP2 in transgenic mice reduces apoptotic signaling after injury.","method":"UCP2 transgenic overexpression mice, brain lesion model, caspase-3 immunohistochemistry, in situ hybridization","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic model with defined apoptotic signaling readout, single lab","pmids":["12147286"],"is_preprint":false},{"year":2000,"finding":"UCP2 mRNA and protein are expressed in specific hypothalamic nuclei (paraventricular, supraoptic, suprachiasmatic, arcuate) and pituitary of nonhuman primates; UCP2 is co-expressed with neuropeptide Y, CRH, oxytocin, and vasopressin in neurons, and with POMC cells in pituitary.","method":"In situ hybridization, immunocytochemistry, co-localization with neuropeptide markers in primate brain sections","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization experiment with co-expression data, no functional manipulation","pmids":["11089557"],"is_preprint":false},{"year":2002,"finding":"UCP2 modulates sensitivity to ethanol and pain/temperature sensation in the CNS; UCP2 overexpressing mice show decreased ethanol sensitivity while UCP2 knockouts show increased sensitivity; UCP2 expression is inversely correlated with ethanol-induced impairment of pain and temperature sensation.","method":"UCP2 transgenic overexpression and knockout mice, acute ethanol challenge, behavioral assays for pain and temperature sensation","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal KO and transgenic overexpression with defined behavioral readouts, single lab","pmids":["12147287"],"is_preprint":false},{"year":1999,"finding":"UCP2 expression in human PAZ6 adipocytes is rapidly upregulated by thiazolidinediones (PPARγ agonists), but the increase parallels general adipocyte differentiation markers, suggesting transcriptional regulation through PPARγ-mediated differentiation rather than a UCP2-specific effect.","method":"RT-PCR of UCP2 mRNA in human adipocytes after thiazolidinedione treatment, time-course experiment","journal":"Diabetologia","confidence":"Low","confidence_rationale":"Tier 3 — single method, confounded by general differentiation effects","pmids":["10333043"],"is_preprint":false},{"year":2024,"finding":"UCP2 overexpression protects retinal endothelial cells from hyperglycemia-induced oxidative stress and senescence through a UCP2-NAD+-SIRT3 axis; UCP2 overexpression attenuates NAD+ downregulation under high glucose, promotes SIRT3 expression and activity, and SIRT3 inhibition abolishes UCP2-mediated protection.","method":"Adenovirus-mediated UCP2 overexpression and knockdown, ROS flow cytometry, SA-β-gal senescence assay, NAD+ measurement, SIRT3 inhibitor (3-TYP) rescue experiment","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — gain/loss of function with pharmacological rescue establishing NAD+-SIRT3 mechanism, single lab","pmids":["38175638"],"is_preprint":false},{"year":2022,"finding":"UCP2 silencing in T-ALL leukemia cells decreases cell proliferation and alters mitochondrial respiration; UCP2 function in malate export enables TCA cycle to provide lipid building blocks for cell growth; glutamine metabolism controls UCP2 expression in T-ALL.","method":"UCP2 siRNA knockdown in T-ALL cell lines, metabolic flux analysis (NMR), Seahorse respirometry, lipid synthesis measurement","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — consistent with reconstituted transport function (PMID 24395786), verified with metabolic flux analysis in leukemia cells, single lab","pmids":["36275699"],"is_preprint":false},{"year":2020,"finding":"UCP2 regulates tubulointerstitial fibrosis by inducing HIF-1α stabilization through mitochondrial respiration and tissue hypoxia; UCP2-deficient mice show reduced renal fibrosis after ischemia-reperfusion; HIF-1α inhibition suppresses lipid and ECM accumulation by restoring PPARα and CPT1α.","method":"UCP2-deficient mice, I/R kidney model, HIF-1α siRNA, lipid deposition measurement, ECM marker Western blot, mitochondrial respiration assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse plus siRNA pathway dissection with defined fibrotic readouts, single lab","pmids":["31932578"],"is_preprint":false},{"year":2017,"finding":"UCP2 overexpression in skin cells (JB6 model) activates PFKFB2 through AKT signaling, elevating fructose 2,6-bisphosphate and glycolytic flux; PFKFB2 inhibition suppresses UCP2-mediated transformation and restores mitochondrial respiration.","method":"UCP2 overexpression in JB6 cells, PFKFB2 knockdown, glucose uptake, lactate production, PFK-1 activity, AKT pathway inhibitor experiments","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway dissection with genetic and pharmacological tools, single lab","pmids":["29221144"],"is_preprint":false}],"current_model":"UCP2 is a mitochondrial inner membrane transporter (not primarily a protonophore) that exports C4 metabolites (malate, oxaloacetate, aspartate) in exchange for phosphate, thereby limiting glucose/acetyl-CoA oxidation and enabling glutaminolysis; its proton conductance activity is regulated positively by fatty acids and retinoids and negatively by nucleotides and glutathionylation, while its transcription is controlled by SIRT1 and KLF2 (shear stress-dependent) and its translation is repressed by a 5' UTR upstream open reading frame, with the net effect of controlling mitochondrial ROS production, AMPK/FoxO1/HIF-1α signaling, and substrate routing in diverse cell types including pancreatic islet cells, macrophages, neurons, and cancer cells."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that UCP2 possesses regulatable proton transport activity resolved whether this UCP1 homolog was itself a functional transporter; retinoids were identified as novel activators and nucleotides as inhibitors, defining UCP2's pharmacological profile.","evidence":"Proton transport assay in yeast mitochondria expressing recombinant UCP2, compared with UCP1 and UCP3","pmids":["10545094"],"confidence":"High","gaps":["Whether retinoid activation is physiologically relevant in vivo remained untested","Molecular mechanism of retinoid-mediated activation unresolved","Transport substrate identity beyond protons was unknown"]},{"year":2004,"claim":"Identifying translational control mechanisms for UCP2 explained how UCP2 protein levels can be rapidly tuned independently of mRNA: a 5′-UTR uORF suppresses translation, and hnRNPK binding to the 3′ UTR promotes translation on polysome-coated mitochondria.","evidence":"Reporter constructs with uORF mutations plus in vitro translation; yeast three-hybrid identification of hnRNPK, polysome fractionation, Western blot quantification","pmids":["16845607","15485813"],"confidence":"Medium","gaps":["Physiological signals that relieve uORF-mediated repression were unidentified","Whether hnRNPK-dependent regulation operates in non-insulin-responsive cells was unknown","Structural basis of uORF-ribosome interaction not determined"]},{"year":2005,"claim":"Demonstrating that SIRT1 directly represses UCP2 transcription in beta cells linked nutrient sensing to mitochondrial uncoupling and insulin secretion, establishing UCP2 as a physiological brake on glucose-stimulated insulin secretion.","evidence":"ChIP showing SIRT1 binding to UCP2 promoter, siRNA rescue of insulin secretion in SIRT1-deficient cells, SIRT1 knockout mice","pmids":["16366736"],"confidence":"High","gaps":["Whether SIRT1-UCP2 axis operates in non-beta-cell contexts was unclear","Identity of histone marks modified by SIRT1 at the UCP2 locus not characterized"]},{"year":2007,"claim":"UCP2 knockout studies in macrophages and islet alpha cells established that UCP2 controls cell-type-specific functions through ROS modulation: UCP2 loss increases macrophage inflammatory cytokine production via MAPK and impairs alpha-cell glucagon secretion by disrupting stimulus-secretion coupling.","evidence":"UCP2 KO mice with macrophage cytokine/NO assays, insulitis scoring; alpha-cell ATP/O ratios, glucagon secretion, mitochondrial membrane potential; conditional alpha-cell KO with ROS rescue","pmids":["18006654","18701716","23434936"],"confidence":"High","gaps":["Whether ROS species mediating effects are superoxide vs. H2O2 was not distinguished","Direct ROS targets in alpha-cell secretory machinery unidentified"]},{"year":2009,"claim":"Showing that ghrelin-mediated neuroprotection of dopamine neurons requires UCP2 established UCP2 as a downstream effector of neuropeptide signaling in the CNS, linking mitochondrial uncoupling to neuronal survival.","evidence":"Genetic epistasis using GHSR KO mice with selective catecholaminergic reactivation, MPTP neurotoxin model, UCP2-dependent mitochondrial respiration and ROS measurements","pmids":["19906954"],"confidence":"High","gaps":["Whether UCP2 induction by ghrelin is transcriptional or translational was unclear","Applicability to human neurodegenerative disease not tested"]},{"year":2011,"claim":"Demonstrating that UCP2 prevents mitochondrial glucose oxidation in stem cells and is required for the glycolysis-to-OXPHOS metabolic transition during differentiation revealed UCP2 as a metabolic gatekeeper of cell fate decisions.","evidence":"siRNA knockdown and ectopic overexpression in human pluripotent stem cells, oxygen consumption and metabolic flux assays, differentiation assays","pmids":["22085932"],"confidence":"High","gaps":["Mechanism by which UCP2 is downregulated during differentiation not established","Whether substrate shunting or proton leak drives the stem cell effect was unresolved"]},{"year":2012,"claim":"Post-translational regulation of UCP2 by glutathionylation was shown to deactivate proton leak, establishing redox-sensitive control of UCP2 activity with implications for chemoresistance in leukemia cells.","evidence":"Diamide-induced glutathionylation with proton leak respiration assay and UCP2 knockdown in drug-resistant leukemia cells","pmids":["23069211"],"confidence":"Medium","gaps":["Specific cysteine residues targeted by glutathionylation not mapped","Whether glutathionylation also regulates the metabolite transport function was untested","No independent replication in other cell types"]},{"year":2014,"claim":"The landmark reconstitution of UCP2 in lipid vesicles redefined its primary molecular function: UCP2 is a C4 metabolite/phosphate exchanger rather than a protonophore, explaining its ability to limit glucose oxidation by exporting oxaloacetate, malate, and aspartate from the mitochondrial matrix.","evidence":"Direct transport assay of reconstituted UCP2 in lipid vesicles; metabolomics and bioenergetic validation in UCP2-silenced HepG2 cells","pmids":["24395786"],"confidence":"High","gaps":["Structural basis for C4 substrate selectivity unknown","How proton leak and metabolite transport activities are related mechanistically was unresolved","In vivo confirmation of transport specificity lacking"]},{"year":2017,"claim":"Multiple studies established UCP2 as a signaling hub linking metabolic substrate routing to downstream kinase pathways: UCP2 modulates FABP4-dependent NLRP3 inflammasome activation in macrophages, ROS-AKT signaling in pancreas development, and AKT-PFKFB2 glycolytic flux in skin cells.","evidence":"FABP4 KO with UCP2 siRNA rescue and inflammasome assays; Ucp2 KO mice with pancreas morphometry and NAC rescue; UCP2 overexpression with AKT/PFKFB2 pathway inhibitor experiments","pmids":["27795298","29079704","29221144"],"confidence":"High","gaps":["Whether ROS-AKT and FABP4-UCP2 axes converge on common effectors was unclear","Relative contributions of metabolite transport vs. uncoupling to these signaling effects not dissected"]},{"year":2019,"claim":"Cell-type-specific conditional knockouts revealed UCP2's roles in microglial biology: UCP2 mediates HFD-induced mitochondrial dynamic changes and hypothalamic inflammation controlling energy balance, and regulates microglial synapse phagocytosis in hippocampus affecting anxiety behavior.","evidence":"Conditional microglial Ucp2 KO with mitochondrial dynamics imaging, POMC neuron activation analysis, synapse phagocytosis confocal imaging, electrophysiology, and behavioral testing","pmids":["31495690","33879866"],"confidence":"High","gaps":["Molecular link between UCP2-dependent ROS and phagocytic machinery not identified","Whether UCP2's metabolite transport or uncoupling function drives microglial effects is unknown"]},{"year":2020,"claim":"UCP2's C4 metabolite transport function was validated in cancer metabolism: UCP2-mediated aspartate efflux fuels cytosolic NADPH production via glutaminolysis in KRAS-mutant pancreatic cancer, and UCP2 loss increases colon tumorigenesis by depleting NADPH and promoting phospholipid synthesis.","evidence":"UCP2 siRNA in KRAS-mutant PDAC cells with metabolic flux, NADPH/NADP+ ratio, xenograft models; UCP2 KO in AOM/DSS and ApcMin/+ colon cancer models with metabolomics","pmids":["33230296","31461648"],"confidence":"High","gaps":["Whether UCP2 transport activity is druggable in cancer contexts is untested","Tissue-specific opposing roles (tumor-promoting vs. tumor-suppressive) not mechanistically reconciled"]},{"year":2022,"claim":"Identification of KLF2 as a shear-stress-responsive transcription factor that directly activates UCP2 in endothelial cells connected UCP2 to vascular mechanotransduction; UCP2 suppresses endothelial inflammation through AMPK-FoxO1 signaling and protects against atherosclerosis.","evidence":"ChIP for KLF2 binding to UCP2 promoter, EC-specific Ucp2 KO and AAV overexpression in vivo, RNA-seq, AMPK/FoxO1 pathway analysis","pmids":["35899624"],"confidence":"High","gaps":["How UCP2 activates AMPK—through metabolite transport, ROS, or AMP/ATP ratio—is not resolved","Whether other shear-responsive transcription factors co-regulate UCP2 is unknown"]},{"year":2022,"claim":"UCP2 was shown to act as a metabolic oxygen sensor in cardiomyocytes, controlling acetyl-CoA levels and histone acetylation under hypoxia, linking UCP2's metabolite transport to epigenetic regulation of cell cycle activity.","evidence":"UCP2 global KO mice under hypoxia with acetyl-CoA measurement, histone acetylation assay, DNA damage markers, cardiomyocyte cell cycle analysis","pmids":["35771638"],"confidence":"Medium","gaps":["Mechanism by which UCP2 senses oxygen not determined","Whether acetyl-CoA changes reflect altered transport or altered TCA flux is unclear","Not confirmed with conditional cardiomyocyte-specific KO"]},{"year":null,"claim":"A unified structural and biophysical model reconciling UCP2's dual activities—C4 metabolite transport and regulatable proton conductance—is lacking, and the relative contribution of each activity to UCP2's diverse cell-type-specific phenotypes remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of UCP2 in a transport-competent state with bound substrate","Cell-type-specific conditional studies have not systematically separated metabolite transport from uncoupling","Druggability of UCP2 transport function is unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,5,6,28]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[5,6]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,5,8,14,18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,5,6,16,21,28]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[7,10,15,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,20,30]}],"complexes":[],"partners":["SIRT1","KLF2","HNRNPK","FABP4","SIRT3"],"other_free_text":[]},"mechanistic_narrative":"UCP2 is a mitochondrial inner membrane protein that governs cellular metabolic routing, mitochondrial ROS production, and downstream signaling across diverse cell types including pancreatic islet cells, macrophages, neurons, endothelial cells, and cancer cells. Reconstitution in lipid vesicles established that UCP2 functions as a C4 metabolite transporter, catalyzing exchange of malate, oxaloacetate, and aspartate for phosphate, thereby limiting mitochondrial glucose oxidation and enabling glutaminolysis and cytosolic NADPH generation [PMID:24395786, PMID:33230296]; its proton conductance is activated by fatty acids and retinoids and inhibited by nucleotides and glutathionylation [PMID:10545094, PMID:23069211]. UCP2 transcription is repressed by SIRT1 in pancreatic beta cells and induced by KLF2 under shear stress in endothelial cells, while translation is restrained by a 5′-UTR upstream open reading frame and modulated by hnRNPK binding to its 3′ UTR [PMID:16366736, PMID:35899624, PMID:16845607, PMID:15485813]. Through its control of mitochondrial ROS, UCP2 regulates AMPK–FoxO1 and HIF-1α signaling, macrophage inflammatory activation, microglial synapse elimination, pancreatic alpha-cell glucagon secretion, stem-cell metabolic transitions, and susceptibility to tumorigenesis [PMID:35899624, PMID:18006654, PMID:33879866, PMID:23434936, PMID:22085932, PMID:31461648]."},"prefetch_data":{"uniprot":{"accession":"P55851","full_name":"Dicarboxylate carrier SLC25A8","aliases":["Mitochondrial uncoupling protein 2","UCP 2","Solute carrier family 25 member 8","UCPH"],"length_aa":309,"mass_kda":33.2,"function":"Antiporter that exports dicarboxylate intermediates of the Krebs cycle in exchange for phosphate plus a proton across the inner membrane of mitochondria, a process driven by mitochondrial motive force with an overall impact on glycolysis, glutaminolysis and glutathione-dependent redox balance. Continuous export of oxaloacetate and related four-carbon dicarboxylates from mitochondrial matrix into the cytosol negatively regulates the oxidation of acetyl-CoA substrates via the Krebs cycle, lowering the ATP/ADP ratio and reactive oxygen species (ROS) production (PubMed:24395786). May mediate inducible proton entry into the mitochondrial matrix affecting ATP turnover as a protection mechanism against oxidative stress. The proton currents are most likely associated with fatty acid flipping across the inner membrane of mitochondria in a metabolic process regulated by free fatty acids and purine nucleotides (By similarity) (PubMed:11171965, PubMed:11278935, PubMed:22524567, PubMed:26182433, PubMed:33373220). Regulates the use of glucose as a source of energy. Required for glucose-induced DRP1-dependent mitochondrial fission and neuron activation in the ventromedial nucleus of the hypothalamus (VMH). This mitochondrial adaptation mechanism modulates the VMH pool of glucose-excited neurons with an impact on systemic glucose homeostasis (By similarity). Regulates ROS levels and metabolic reprogramming of macrophages during the resolution phase of inflammation. Attenuates ROS production in response to IL33 to preserve the integrity of the Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages (By similarity). Can unidirectionally transport anions including L-malate, L-aspartate, phosphate and chloride ions (PubMed:22524567, PubMed:24395786, PubMed:26182433). Does not mediate adaptive thermogenesis (By similarity)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/P55851/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/UCP2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/UCP2","total_profiled":1310},"omim":[{"mim_id":"613725","title":"SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27","url":"https://www.omim.org/entry/613725"},{"mim_id":"609911","title":"SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 47; SLC25A47","url":"https://www.omim.org/entry/609911"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"607946","title":"ADIPONECTIN RECEPTOR 2; ADIPOR2","url":"https://www.omim.org/entry/607946"},{"mim_id":"607945","title":"ADIPONECTIN RECEPTOR 1; ADIPOR1","url":"https://www.omim.org/entry/607945"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":260.0}],"url":"https://www.proteinatlas.org/search/UCP2"},"hgnc":{"alias_symbol":["SLC25A8"],"prev_symbol":["BMIQ4"]},"alphafold":{"accession":"P55851","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55851","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55851-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55851-F1-predicted_aligned_error_v6.png","plddt_mean":62.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=UCP2","jax_strain_url":"https://www.jax.org/strain/search?query=UCP2"},"sequence":{"accession":"P55851","fasta_url":"https://rest.uniprot.org/uniprotkb/P55851.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55851/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55851"}},"corpus_meta":[{"pmid":"10620491","id":"PMC_10620491","title":"The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10620491","citation_count":640,"is_preprint":false},{"pmid":"16366736","id":"PMC_16366736","title":"Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells.","date":"2005","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/16366736","citation_count":600,"is_preprint":false},{"pmid":"22085932","id":"PMC_22085932","title":"UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22085932","citation_count":409,"is_preprint":false},{"pmid":"24395786","id":"PMC_24395786","title":"UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24395786","citation_count":336,"is_preprint":false},{"pmid":"9700198","id":"PMC_9700198","title":"Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9700198","citation_count":251,"is_preprint":false},{"pmid":"19906954","id":"PMC_19906954","title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19906954","citation_count":232,"is_preprint":false},{"pmid":"31384530","id":"PMC_31384530","title":"Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway.","date":"2019","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/31384530","citation_count":223,"is_preprint":false},{"pmid":"12525856","id":"PMC_12525856","title":"The 'novel' 'uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions.","date":"2003","source":"Experimental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12525856","citation_count":194,"is_preprint":false},{"pmid":"31495690","id":"PMC_31495690","title":"Microglial UCP2 Mediates Inflammation and Obesity Induced by High-Fat Feeding.","date":"2019","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31495690","citation_count":193,"is_preprint":false},{"pmid":"21917523","id":"PMC_21917523","title":"Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism.","date":"2011","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21917523","citation_count":179,"is_preprint":false},{"pmid":"18308829","id":"PMC_18308829","title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18308829","citation_count":175,"is_preprint":false},{"pmid":"10545094","id":"PMC_10545094","title":"Retinoids activate proton transport by the uncoupling proteins UCP1 and UCP2.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10545094","citation_count":172,"is_preprint":false},{"pmid":"16487034","id":"PMC_16487034","title":"The emerging functions of UCP2 in health, disease, and therapeutics.","date":"2006","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/16487034","citation_count":151,"is_preprint":false},{"pmid":"23807210","id":"PMC_23807210","title":"UCP2, a mitochondrial protein regulated at multiple levels.","date":"2013","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23807210","citation_count":143,"is_preprint":false},{"pmid":"30027365","id":"PMC_30027365","title":"A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis.","date":"2018","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/30027365","citation_count":127,"is_preprint":false},{"pmid":"19413946","id":"PMC_19413946","title":"UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19413946","citation_count":114,"is_preprint":false},{"pmid":"19413708","id":"PMC_19413708","title":"The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes.","date":"2009","source":"Obesity reviews : an official journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/19413708","citation_count":113,"is_preprint":false},{"pmid":"33230296","id":"PMC_33230296","title":"KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.","date":"2020","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33230296","citation_count":107,"is_preprint":false},{"pmid":"12147286","id":"PMC_12147286","title":"Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury.","date":"2002","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12147286","citation_count":104,"is_preprint":false},{"pmid":"20227410","id":"PMC_20227410","title":"Uncoupling protein UCP2: when mitochondrial activity meets immunity.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20227410","citation_count":101,"is_preprint":false},{"pmid":"25582199","id":"PMC_25582199","title":"Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25582199","citation_count":85,"is_preprint":false},{"pmid":"23124112","id":"PMC_23124112","title":"UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23124112","citation_count":81,"is_preprint":false},{"pmid":"11287359","id":"PMC_11287359","title":"T(3) increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3.","date":"2001","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11287359","citation_count":80,"is_preprint":false},{"pmid":"27795298","id":"PMC_27795298","title":"FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27795298","citation_count":78,"is_preprint":false},{"pmid":"29547569","id":"PMC_29547569","title":"Melatonin Balance the Autophagy and Apoptosis by Regulating UCP2 in the LPS-Induced Cardiomyopathy.","date":"2018","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29547569","citation_count":76,"is_preprint":false},{"pmid":"21779625","id":"PMC_21779625","title":"The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications.","date":"2011","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/21779625","citation_count":73,"is_preprint":false},{"pmid":"23607427","id":"PMC_23607427","title":"TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction.","date":"2013","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/23607427","citation_count":73,"is_preprint":false},{"pmid":"17209127","id":"PMC_17209127","title":"Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17209127","citation_count":73,"is_preprint":false},{"pmid":"12032169","id":"PMC_12032169","title":"PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells.","date":"2002","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12032169","citation_count":72,"is_preprint":false},{"pmid":"24853548","id":"PMC_24853548","title":"Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24853548","citation_count":71,"is_preprint":false},{"pmid":"30952098","id":"PMC_30952098","title":"UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30952098","citation_count":69,"is_preprint":false},{"pmid":"18006654","id":"PMC_18006654","title":"Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18006654","citation_count":65,"is_preprint":false},{"pmid":"25703824","id":"PMC_25703824","title":"Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.","date":"2015","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/25703824","citation_count":64,"is_preprint":false},{"pmid":"18301432","id":"PMC_18301432","title":"Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse.","date":"2008","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18301432","citation_count":64,"is_preprint":false},{"pmid":"18701716","id":"PMC_18701716","title":"UCP2 is highly expressed in pancreatic alpha-cells and influences secretion and survival.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18701716","citation_count":61,"is_preprint":false},{"pmid":"23434936","id":"PMC_23434936","title":"UCP2 regulates the glucagon response to fasting and starvation.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23434936","citation_count":61,"is_preprint":false},{"pmid":"35899624","id":"PMC_35899624","title":"Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/35899624","citation_count":60,"is_preprint":false},{"pmid":"28258342","id":"PMC_28258342","title":"COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.","date":"2017","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28258342","citation_count":57,"is_preprint":false},{"pmid":"19864106","id":"PMC_19864106","title":"Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2.","date":"2009","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/19864106","citation_count":56,"is_preprint":false},{"pmid":"30318520","id":"PMC_30318520","title":"Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells.","date":"2018","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30318520","citation_count":56,"is_preprint":false},{"pmid":"31330574","id":"PMC_31330574","title":"UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/31330574","citation_count":55,"is_preprint":false},{"pmid":"28214555","id":"PMC_28214555","title":"Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation.","date":"2017","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/28214555","citation_count":54,"is_preprint":false},{"pmid":"28765172","id":"PMC_28765172","title":"Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28765172","citation_count":52,"is_preprint":false},{"pmid":"28104982","id":"PMC_28104982","title":"miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.","date":"2017","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/28104982","citation_count":50,"is_preprint":false},{"pmid":"31932578","id":"PMC_31932578","title":"UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31932578","citation_count":49,"is_preprint":false},{"pmid":"31811866","id":"PMC_31811866","title":"UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31811866","citation_count":46,"is_preprint":false},{"pmid":"16845607","id":"PMC_16845607","title":"Translation control of UCP2 synthesis by the upstream open reading frame.","date":"2006","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/16845607","citation_count":46,"is_preprint":false},{"pmid":"11089557","id":"PMC_11089557","title":"Mitochondrial uncoupling protein 2 (UCP2) in the nonhuman primate brain and pituitary.","date":"2000","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11089557","citation_count":45,"is_preprint":false},{"pmid":"34625529","id":"PMC_34625529","title":"An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34625529","citation_count":44,"is_preprint":false},{"pmid":"34326395","id":"PMC_34326395","title":"Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34326395","citation_count":42,"is_preprint":false},{"pmid":"31461648","id":"PMC_31461648","title":"UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31461648","citation_count":39,"is_preprint":false},{"pmid":"23069211","id":"PMC_23069211","title":"Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeutics.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23069211","citation_count":38,"is_preprint":false},{"pmid":"28755631","id":"PMC_28755631","title":"Upregulation of UCP2 in beta-cells confers partial protection against both oxidative stress and glucotoxicity.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28755631","citation_count":38,"is_preprint":false},{"pmid":"25251374","id":"PMC_25251374","title":"UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells.","date":"2015","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25251374","citation_count":37,"is_preprint":false},{"pmid":"29221144","id":"PMC_29221144","title":"UCP2 overexpression enhanced glycolysis via activation of PFKFB2 during skin cell transformation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29221144","citation_count":36,"is_preprint":false},{"pmid":"30225723","id":"PMC_30225723","title":"Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.","date":"2018","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30225723","citation_count":36,"is_preprint":false},{"pmid":"36499405","id":"PMC_36499405","title":"UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36499405","citation_count":35,"is_preprint":false},{"pmid":"35628447","id":"PMC_35628447","title":"Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628447","citation_count":35,"is_preprint":false},{"pmid":"31071510","id":"PMC_31071510","title":"UCP2 alleviates tubular epithelial cell apoptosis in lipopolysaccharide-induced acute kidney injury by decreasing ROS production.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31071510","citation_count":35,"is_preprint":false},{"pmid":"15485813","id":"PMC_15485813","title":"Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15485813","citation_count":33,"is_preprint":false},{"pmid":"36699054","id":"PMC_36699054","title":"Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36699054","citation_count":32,"is_preprint":false},{"pmid":"29079704","id":"PMC_29079704","title":"Mitochondrial Protein UCP2 Controls Pancreas Development.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29079704","citation_count":31,"is_preprint":false},{"pmid":"24564667","id":"PMC_24564667","title":"Antioxidant and regulatory role of mitochondrial uncoupling protein UCP2 in pancreatic beta-cells.","date":"2014","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/24564667","citation_count":31,"is_preprint":false},{"pmid":"31182990","id":"PMC_31182990","title":"Upregulation of UCP2 Expression Protects against LPS-Induced Oxidative Stress and Apoptosis in Cardiomyocytes.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31182990","citation_count":31,"is_preprint":false},{"pmid":"18167556","id":"PMC_18167556","title":"UCP-2 and UCP-3 proteins are differentially regulated in pancreatic beta-cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18167556","citation_count":31,"is_preprint":false},{"pmid":"37679327","id":"PMC_37679327","title":"Exploring a new mechanism between lactate and VSMC calcification: PARP1/POLG/UCP2 signaling pathway and imbalance of mitochondrial homeostasis.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37679327","citation_count":30,"is_preprint":false},{"pmid":"30235442","id":"PMC_30235442","title":"Genipin Reverses HFD-Induced Liver Damage and Inhibits UCP2-Mediated Pyroptosis in Mice.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30235442","citation_count":29,"is_preprint":false},{"pmid":"12147287","id":"PMC_12147287","title":"Uncoupling protein 2 (UCP2) lowers alcohol sensitivity and pain threshold.","date":"2002","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12147287","citation_count":28,"is_preprint":false},{"pmid":"34168453","id":"PMC_34168453","title":"ShenmaYizhi Decoction Improves the Mitochondrial Structure in the Brain and Ameliorates Cognitive Impairment in VCI Rats via the AMPK/UCP2 Signaling Pathway.","date":"2021","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/34168453","citation_count":28,"is_preprint":false},{"pmid":"10333043","id":"PMC_10333043","title":"Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes.","date":"1999","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10333043","citation_count":27,"is_preprint":false},{"pmid":"33879866","id":"PMC_33879866","title":"Ucp2-dependent microglia-neuronal coupling controls ventral hippocampal circuit function and anxiety-like behavior.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33879866","citation_count":26,"is_preprint":false},{"pmid":"27179975","id":"PMC_27179975","title":"Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.","date":"2016","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27179975","citation_count":26,"is_preprint":false},{"pmid":"12785014","id":"PMC_12785014","title":"Cardiac UCP2 expression and myocardial oxidative metabolism during acute septic shock in the rat.","date":"2003","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/12785014","citation_count":25,"is_preprint":false},{"pmid":"29887950","id":"PMC_29887950","title":"Overexpressed UCP2 regulates mitochondrial flashes and reverses lipopolysaccharide-induced cardiomyocytes injury.","date":"2018","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/29887950","citation_count":25,"is_preprint":false},{"pmid":"17512314","id":"PMC_17512314","title":"Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women.","date":"2007","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/17512314","citation_count":25,"is_preprint":false},{"pmid":"30431098","id":"PMC_30431098","title":"PEDF protects human retinal pigment epithelial cells against oxidative stress via upregulation of UCP2 expression.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30431098","citation_count":24,"is_preprint":false},{"pmid":"33746782","id":"PMC_33746782","title":"Hypoxanthine Induces Muscular ATP Depletion and Fatigue via UCP2.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33746782","citation_count":23,"is_preprint":false},{"pmid":"10440124","id":"PMC_10440124","title":"Regulation of UCP2 and UCP3 by muscle disuse and physical activity in tetraplegic subjects.","date":"1999","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/10440124","citation_count":23,"is_preprint":false},{"pmid":"35771638","id":"PMC_35771638","title":"UCP2 modulates cardiomyocyte cell cycle activity, acetyl-CoA, and histone acetylation in response to moderate hypoxia.","date":"2022","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/35771638","citation_count":22,"is_preprint":false},{"pmid":"27257601","id":"PMC_27257601","title":"Role of mitochondrial uncoupling protein-2 (UCP2) in higher brain functions, neuronal plasticity and network oscillation.","date":"2016","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27257601","citation_count":22,"is_preprint":false},{"pmid":"21883184","id":"PMC_21883184","title":"Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population.","date":"2011","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21883184","citation_count":22,"is_preprint":false},{"pmid":"34183754","id":"PMC_34183754","title":"Activation of UCP2 by anethole trithione suppresses neuroinflammation after intracerebral hemorrhage.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34183754","citation_count":21,"is_preprint":false},{"pmid":"32654534","id":"PMC_32654534","title":"Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathways.","date":"2020","source":"Archives of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32654534","citation_count":21,"is_preprint":false},{"pmid":"11467409","id":"PMC_11467409","title":"Correlation between pancreatic islet uncoupling protein-2 (UCP2) mRNA concentration and insulin status in rats.","date":"2000","source":"International journal of experimental diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/11467409","citation_count":21,"is_preprint":false},{"pmid":"14759071","id":"PMC_14759071","title":"Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians.","date":"2003","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/14759071","citation_count":21,"is_preprint":false},{"pmid":"23504111","id":"PMC_23504111","title":"UCP2 and ANT differently modulate proton-leak in brain mitochondria of long-term hyperglycemic and recurrent hypoglycemic rats.","date":"2013","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/23504111","citation_count":21,"is_preprint":false},{"pmid":"31085159","id":"PMC_31085159","title":"UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31085159","citation_count":19,"is_preprint":false},{"pmid":"33708886","id":"PMC_33708886","title":"The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism.","date":"2021","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33708886","citation_count":19,"is_preprint":false},{"pmid":"35457171","id":"PMC_35457171","title":"Microglial FABP4-UCP2 Axis Modulates Neuroinflammation and Cognitive Decline in Obese Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35457171","citation_count":18,"is_preprint":false},{"pmid":"37744277","id":"PMC_37744277","title":"CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway.","date":"2023","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/37744277","citation_count":18,"is_preprint":false},{"pmid":"34580604","id":"PMC_34580604","title":"PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/34580604","citation_count":18,"is_preprint":false},{"pmid":"39900919","id":"PMC_39900919","title":"Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39900919","citation_count":17,"is_preprint":false},{"pmid":"15694840","id":"PMC_15694840","title":"Recruitment of mitochondrial uncoupling protein UCP2 after lipopolysaccharide induction.","date":"2005","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15694840","citation_count":17,"is_preprint":false},{"pmid":"26621256","id":"PMC_26621256","title":"Expression of UCP2 in Wistar rats varies according to age and the severity of obesity.","date":"2015","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26621256","citation_count":16,"is_preprint":false},{"pmid":"25003714","id":"PMC_25003714","title":"Hippocampal UCP2 is essential for cognition and resistance to anxiety but not required for the benefits of exercise.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25003714","citation_count":16,"is_preprint":false},{"pmid":"38175638","id":"PMC_38175638","title":"UCP2-SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/38175638","citation_count":15,"is_preprint":false},{"pmid":"36275699","id":"PMC_36275699","title":"UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36275699","citation_count":15,"is_preprint":false},{"pmid":"32560241","id":"PMC_32560241","title":"Brain Overexpression of Uncoupling Protein-2 (UCP2) Delays Renal Damage and Stroke Occurrence in Stroke-Prone Spontaneously Hypertensive Rats.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32560241","citation_count":15,"is_preprint":false},{"pmid":"35488517","id":"PMC_35488517","title":"Endothelial Cells Mediated by UCP2 Control the Neurogenic-to-Astrogenic Neural Stem Cells Fate Switch During Brain Development.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35488517","citation_count":15,"is_preprint":false},{"pmid":"23147265","id":"PMC_23147265","title":"An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23147265","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50110,"output_tokens":7107,"usd":0.128468},"stage2":{"model":"claude-opus-4-6","input_tokens":10851,"output_tokens":3713,"usd":0.22062},"total_usd":0.349088,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Retinoids (retinoic acid) activate proton transport by UCP2 in a pH-dependent manner, demonstrated using yeast mitochondria expressing UCP2 by genetic manipulation; UCP2 proton conductance is positively regulated by retinoids and negatively regulated by nucleotides, analogous to UCP1 but with distinct pharmacology.\",\n      \"method\": \"In vitro proton transport assay in yeast mitochondria expressing recombinant UCP2; comparison with UCP1 and UCP3\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted activity in yeast expression system with direct transport measurements, orthogonal comparison across UCP family members\",\n      \"pmids\": [\"10545094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SIRT1 represses UCP2 transcription by binding directly to the UCP2 promoter in pancreatic beta cells; reduced SIRT1 leads to elevated UCP2, blunted ATP production after glucose stimulation, and impaired insulin secretion; UCP2 knockdown rescues insulin secretion in SIRT1-deficient cells.\",\n      \"method\": \"ChIP (SIRT1 binding to UCP2 promoter), siRNA knockdown of SIRT1 and UCP2, glucose-stimulated insulin secretion assay, SIRT1 knockout mice\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, siRNA rescue, KO mice) in single high-citation study\",\n      \"pmids\": [\"16366736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"UCP2 mRNA translation is controlled by an upstream open reading frame (uORF) in its 5' UTR encoding a 36-amino-acid peptide; the 3' region of the uORF is the major determinant of translational inhibition, and silent single-base substitutions in this region significantly alter UCP2 translation.\",\n      \"method\": \"Reporter constructs with uORF mutations, in vitro translation assays\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of regulatory element with direct functional readout, single study\",\n      \"pmids\": [\"16845607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"hnRNPK (heterogeneous nuclear ribonucleoprotein K) binds to the 3' UTR of ucp2 mRNA and associates with polysome-coated mitochondria; hnRNPK overexpression augments insulin-induced mitochondrial UCP2 protein levels without changing mRNA levels, indicating translational regulation.\",\n      \"method\": \"Yeast three-hybrid screen, co-immunoprecipitation, polysome fractionation, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast three-hybrid plus polysome fractionation and functional protein quantification, single lab\",\n      \"pmids\": [\"15485813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"UCP2 prevents mitochondrial glucose oxidation in human pluripotent stem cells (hPSCs) and facilitates glycolysis via a substrate shunting mechanism; ectopic UCP2 expression perturbs the metabolic transition during differentiation and impairs differentiation potential.\",\n      \"method\": \"siRNA knockdown and ectopic overexpression of UCP2, oxygen consumption measurements, metabolic flux assays, differentiation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function with defined metabolic and differentiation readouts, multiple methods\",\n      \"pmids\": [\"22085932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"UCP2 functions as a mitochondrial metabolite transporter: when reconstituted in lipid vesicles, UCP2 catalyzes exchange of malate, oxaloacetate, and aspartate for phosphate plus a proton; by exporting C4 compounds out of mitochondria, UCP2 limits glucose oxidation and enhances glutaminolysis.\",\n      \"method\": \"Reconstitution of UCP2 in lipid vesicles with direct transport assay; metabolomics of siUCP2-HepG2 cells; mitochondrial membrane potential and ATP:ADP measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro reconstitution of transport activity plus cellular validation with multiple metabolic readouts\",\n      \"pmids\": [\"24395786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UCP2 catalyzes aspartate efflux from mitochondria in KRAS-mutant pancreatic cancer cells, connecting mitochondrial glutamine metabolism to cytosolic NADPH production; UCP2 silencing decreases glutaminolysis, lowers NADPH/NADP+ and glutathione ratios, increases ROS, and suppresses KRASmut PDAC cell growth in vitro and in vivo.\",\n      \"method\": \"UCP2 siRNA knockdown, metabolic flux assays, NADPH/NADP+ measurement, ROS detection, xenograft tumor models\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic link to transport activity established in PMID 24395786, confirmed here with in vivo tumor models and multiple metabolic readouts\",\n      \"pmids\": [\"33230296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Glutathionylation of UCP2 deactivates proton leak; chemical induction of glutathionylation (diamide) selectively inhibits proton leak through UCP2 in drug-resistant leukemia (Mx2) cells, disabling chemoresistance; UCP2 knockdown reduces state 4 (proton leak-dependent) respiration by ~62%.\",\n      \"method\": \"Diamide-induced glutathionylation, proton leak respiration assay, UCP2 knockdown, cell viability with chemotherapeutics\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct manipulation of PTM (glutathionylation) with functional respiratory readout, single lab\",\n      \"pmids\": [\"23069211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UCP2 is expressed at significantly higher levels in pancreatic alpha-cells than beta-cells; reducing UCP2 activity in alpha-cells increases mitochondrial membrane potential and ATP synthesis efficiency, leads to reduced glucagon secretion at low glucose, and increases alpha-cell sensitivity to death stimuli.\",\n      \"method\": \"UCP2−/− mice, mitochondrial membrane potential measurement, ATP/O ratio, glucagon secretion assays, cell death assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse with multiple orthogonal readouts (bioenergetics, secretion, survival), replicated across in vitro and in vivo\",\n      \"pmids\": [\"18701716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Alpha-cell-specific UCP2 deletion impairs glucagon secretion in response to hypoglycemia; UCP2-deleted alpha-cells accumulate intracellular ROS due to enhanced mitochondrial coupling, which directly perturbs stimulus-secretion coupling; exogenous ROS application mimics UCP2 deletion effects on glucagon secretion.\",\n      \"method\": \"Alpha-cell-specific UCP2 knockout mice, ROS measurement, glucagon secretion assay, genipin pharmacological inhibition of UCP2, human islet studies\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO plus pharmacological inhibitor plus ROS rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"23434936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UCP2 controls macrophage activation by modulating mitochondrial ROS production and MAPK signaling; UCP2-deficient macrophages show increased IL-1β and nitric oxide production, leading to accelerated autoimmune diabetes in a streptozotocin model.\",\n      \"method\": \"UCP2 knockout mice, macrophage cytokine assays, NO measurement, insulitis scoring\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined cellular mechanism (ROS/MAPK), multiple inflammatory readouts\",\n      \"pmids\": [\"18006654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ghrelin-induced neuroprotection of nigrostriatal dopamine neurons is dependent on UCP2-mediated alterations in mitochondrial respiration, ROS production, and biogenesis; ghrelin receptor (GHSR) activation in substantia nigra requires UCP2 for its mitochondrial redox mechanism of protection.\",\n      \"method\": \"Ghrelin/GHSR knockout mice, MPTP neurotoxin model, selective GHSR reactivation in catecholaminergic neurons, mitochondrial respiration and ROS assays, UCP2-dependent rescue experiments\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (GHSR KO + UCP2 dependence) with mitochondrial functional readouts in vivo\",\n      \"pmids\": [\"19906954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Microglial UCP2 mediates HFD-induced changes in mitochondrial dynamics and microglia activation; selective microglial deletion of Ucp2 prevents mitochondrial dynamic changes, microglia activation, and hypothalamic inflammation, protecting mice from diet-induced obesity with decreased feeding and increased energy expenditure.\",\n      \"method\": \"Conditional microglial Ucp2 knockout, mitochondrial dynamics imaging, hypothalamic inflammation markers, synaptic input analysis, POMC neuron activation\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with mechanistic readouts linking mitochondrial function to hypothalamic circuit activity and obesity\",\n      \"pmids\": [\"31495690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Microglial UCP2 regulates phasic elimination of spine synapses in ventral hippocampus; conditional Ucp2 ablation from microglia impairs synapse phagocytosis, causes ROS accumulation and lysosome-lipid droplet complex formation, resulting in hippocampal circuit dysfunction and altered anxiety-like behavior.\",\n      \"method\": \"Conditional microglial Ucp2 KO, confocal imaging of microglia-synapse contacts, ROS assay, electrophysiology, behavioral testing\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with mechanistic cellular and circuit-level readouts\",\n      \"pmids\": [\"33879866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UCP2 upregulation in NASH liver induces mitochondrial proton leak, measured directly as increased proton conductance in isolated mitochondria; this correlates with increased H2O2 production and decreased ATP content, reducing the liver's ability to respond to acute energy demands such as ischemia-reperfusion.\",\n      \"method\": \"Isolated mitochondria proton leak measurement, H2O2 synthesis assay, GSH/GSSG ratio, ATP homeostasis in NASH rat model and human biopsy samples\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mitochondrial bioenergetic measurements in both rat model and human tissue, single lab\",\n      \"pmids\": [\"18308829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 controls mitochondrial ROS and MAPK signaling in macrophages through the FABP4-UCP2 axis; FABP4 deletion elevates intracellular free fatty acids and increases UCP2 expression, reducing ER stress, NLRP3 inflammasome activation, and IL-1β secretion; these effects are reversed by UCP2 silencing.\",\n      \"method\": \"FABP4/aP2 knockout and pharmacological inhibition, UCP2 siRNA, inflammasome activation assays, mitochondrial protein oxidation proteomics\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological manipulation with rescue by UCP2 silencing, multiple orthogonal mechanistic readouts\",\n      \"pmids\": [\"27795298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"UCP2 overexpression in cancer cells restores oxidative phosphorylation balance (reversing Warburg effect) through substrate routing (not membrane potential uncoupling), activates AMPK signaling, and downregulates HIF expression, repressing malignant phenotypes.\",\n      \"method\": \"UCP2 overexpression in cancer cell lines, Seahorse metabolic flux analysis, AMPK and HIF protein measurement, tumorigenesis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple metabolic and signaling readouts, mechanistic distinction from uncoupling activity, single lab\",\n      \"pmids\": [\"24853548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In endothelial cells, KLF2 directly binds the UCP2 promoter to upregulate its transcription in response to unidirectional shear stress; UCP2 suppresses endothelial inflammation through AMPK-mediated inhibition of FoxO1; EC-specific Ucp2 deletion promotes atherosclerosis, while AAV-mediated overexpression inhibits it.\",\n      \"method\": \"ChIP (KLF2 binding to UCP2 promoter), shear stress simulation, EC-specific Ucp2 KO mice, AAV-mediated overexpression, RNA-seq, AMPK/FoxO1 pathway analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding (ChIP), conditional KO and overexpression in vivo, multiple pathway readouts\",\n      \"pmids\": [\"35899624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"UCP2 is recruited to hepatocyte mitochondria after LPS challenge; LPS increases UCP2 protein 3-fold (quantified by 3H-GTP binding sites), reduces mitochondrial membrane potential, and increases H2O2 production reversed by GDP (UCP2 inhibitor), indicating functional UCP2-mediated uncoupling in hepatocytes during infection.\",\n      \"method\": \"3H-GTP binding assay for UCP2 protein quantification, mitochondrial membrane potential (JC-1), H2O2 assay with GDP inhibition, real-time RT-PCR\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct quantification of functional UCP2 using radioligand binding plus GDP-sensitive H2O2 assay, single lab\",\n      \"pmids\": [\"15694840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells; UCP2 overexpression reduces basal autophagy, establishing an anti-autophagic role for UCP2 through ROS control.\",\n      \"method\": \"Genipin pharmacological inhibition and siRNA knockdown of UCP2, ROS measurement, GAPDH nuclear translocation assay, autophagosome formation, LC3-II Western blot, UCP2 overexpression\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss of function with defined mechanistic pathway, single lab\",\n      \"pmids\": [\"23124112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 controls pancreas development through a ROS-AKT signaling pathway; Ucp2 knockout mice show increased PDX1+ progenitor cells and expanded alpha- and beta-cell mass, associated with increased NRF2 nuclear translocation and AKT phosphorylation; N-acetylcysteine administration rescued the pancreatic developmental phenotype.\",\n      \"method\": \"Ucp2 knockout mice, pancreas morphometry, ROS measurement, NRF2 nuclear translocation assay, pAKT Western blot, antioxidant rescue experiment\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype rescued by antioxidant treatment establishing ROS-AKT mechanism, multiple orthogonal readouts\",\n      \"pmids\": [\"29079704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"UCP2 deficiency increases colon tumorigenesis by promoting phospholipid synthesis and depleting NADPH for antioxidant defenses; UCP2 loss alters glycolytic pathways and increases oxidized glutathione levels, rendering colon cells more prone to malignant transformation.\",\n      \"method\": \"UCP2 KO in AOM/DSS and ApcMin/+ mouse cancer models, metabolomics (NADPH, glutathione oxidation, phospholipid), tumor histopathology\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo cancer models with defined metabolic mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"31461648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UCP2 acts as a metabolic oxygen sensor in cardiomyocytes; under moderate hypoxia, UCP2 increases acetyl-CoA levels and histone acetylation, promoting cardiomyocyte cell cycle activity; UCP2 knockout under hypoxia reduces cardiomyocyte cell cycle activity, increases DNA damage and fibrosis.\",\n      \"method\": \"UCP2 global KO mice under hypoxia, acetyl-CoA measurement, histone acetylation assay, chromatin modifier analysis, DNA damage markers, cardiomyocyte cell cycle analysis\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with mechanistic acetyl-CoA/histone acetylation readouts, single lab\",\n      \"pmids\": [\"35771638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"UCP2 is expressed in neurons of subcortical brain regions and is rapidly induced after brain lesions with an inverse relationship to caspase-3 activation; overexpression of UCP2 in transgenic mice reduces apoptotic signaling after injury.\",\n      \"method\": \"UCP2 transgenic overexpression mice, brain lesion model, caspase-3 immunohistochemistry, in situ hybridization\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic model with defined apoptotic signaling readout, single lab\",\n      \"pmids\": [\"12147286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"UCP2 mRNA and protein are expressed in specific hypothalamic nuclei (paraventricular, supraoptic, suprachiasmatic, arcuate) and pituitary of nonhuman primates; UCP2 is co-expressed with neuropeptide Y, CRH, oxytocin, and vasopressin in neurons, and with POMC cells in pituitary.\",\n      \"method\": \"In situ hybridization, immunocytochemistry, co-localization with neuropeptide markers in primate brain sections\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization experiment with co-expression data, no functional manipulation\",\n      \"pmids\": [\"11089557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"UCP2 modulates sensitivity to ethanol and pain/temperature sensation in the CNS; UCP2 overexpressing mice show decreased ethanol sensitivity while UCP2 knockouts show increased sensitivity; UCP2 expression is inversely correlated with ethanol-induced impairment of pain and temperature sensation.\",\n      \"method\": \"UCP2 transgenic overexpression and knockout mice, acute ethanol challenge, behavioral assays for pain and temperature sensation\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal KO and transgenic overexpression with defined behavioral readouts, single lab\",\n      \"pmids\": [\"12147287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"UCP2 expression in human PAZ6 adipocytes is rapidly upregulated by thiazolidinediones (PPARγ agonists), but the increase parallels general adipocyte differentiation markers, suggesting transcriptional regulation through PPARγ-mediated differentiation rather than a UCP2-specific effect.\",\n      \"method\": \"RT-PCR of UCP2 mRNA in human adipocytes after thiazolidinedione treatment, time-course experiment\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method, confounded by general differentiation effects\",\n      \"pmids\": [\"10333043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"UCP2 overexpression protects retinal endothelial cells from hyperglycemia-induced oxidative stress and senescence through a UCP2-NAD+-SIRT3 axis; UCP2 overexpression attenuates NAD+ downregulation under high glucose, promotes SIRT3 expression and activity, and SIRT3 inhibition abolishes UCP2-mediated protection.\",\n      \"method\": \"Adenovirus-mediated UCP2 overexpression and knockdown, ROS flow cytometry, SA-β-gal senescence assay, NAD+ measurement, SIRT3 inhibitor (3-TYP) rescue experiment\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain/loss of function with pharmacological rescue establishing NAD+-SIRT3 mechanism, single lab\",\n      \"pmids\": [\"38175638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UCP2 silencing in T-ALL leukemia cells decreases cell proliferation and alters mitochondrial respiration; UCP2 function in malate export enables TCA cycle to provide lipid building blocks for cell growth; glutamine metabolism controls UCP2 expression in T-ALL.\",\n      \"method\": \"UCP2 siRNA knockdown in T-ALL cell lines, metabolic flux analysis (NMR), Seahorse respirometry, lipid synthesis measurement\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — consistent with reconstituted transport function (PMID 24395786), verified with metabolic flux analysis in leukemia cells, single lab\",\n      \"pmids\": [\"36275699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"UCP2 regulates tubulointerstitial fibrosis by inducing HIF-1α stabilization through mitochondrial respiration and tissue hypoxia; UCP2-deficient mice show reduced renal fibrosis after ischemia-reperfusion; HIF-1α inhibition suppresses lipid and ECM accumulation by restoring PPARα and CPT1α.\",\n      \"method\": \"UCP2-deficient mice, I/R kidney model, HIF-1α siRNA, lipid deposition measurement, ECM marker Western blot, mitochondrial respiration assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse plus siRNA pathway dissection with defined fibrotic readouts, single lab\",\n      \"pmids\": [\"31932578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCP2 overexpression in skin cells (JB6 model) activates PFKFB2 through AKT signaling, elevating fructose 2,6-bisphosphate and glycolytic flux; PFKFB2 inhibition suppresses UCP2-mediated transformation and restores mitochondrial respiration.\",\n      \"method\": \"UCP2 overexpression in JB6 cells, PFKFB2 knockdown, glucose uptake, lactate production, PFK-1 activity, AKT pathway inhibitor experiments\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway dissection with genetic and pharmacological tools, single lab\",\n      \"pmids\": [\"29221144\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"UCP2 is a mitochondrial inner membrane transporter (not primarily a protonophore) that exports C4 metabolites (malate, oxaloacetate, aspartate) in exchange for phosphate, thereby limiting glucose/acetyl-CoA oxidation and enabling glutaminolysis; its proton conductance activity is regulated positively by fatty acids and retinoids and negatively by nucleotides and glutathionylation, while its transcription is controlled by SIRT1 and KLF2 (shear stress-dependent) and its translation is repressed by a 5' UTR upstream open reading frame, with the net effect of controlling mitochondrial ROS production, AMPK/FoxO1/HIF-1α signaling, and substrate routing in diverse cell types including pancreatic islet cells, macrophages, neurons, and cancer cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"UCP2 is a mitochondrial inner membrane protein that governs cellular metabolic routing, mitochondrial ROS production, and downstream signaling across diverse cell types including pancreatic islet cells, macrophages, neurons, endothelial cells, and cancer cells. Reconstitution in lipid vesicles established that UCP2 functions as a C4 metabolite transporter, catalyzing exchange of malate, oxaloacetate, and aspartate for phosphate, thereby limiting mitochondrial glucose oxidation and enabling glutaminolysis and cytosolic NADPH generation [PMID:24395786, PMID:33230296]; its proton conductance is activated by fatty acids and retinoids and inhibited by nucleotides and glutathionylation [PMID:10545094, PMID:23069211]. UCP2 transcription is repressed by SIRT1 in pancreatic beta cells and induced by KLF2 under shear stress in endothelial cells, while translation is restrained by a 5′-UTR upstream open reading frame and modulated by hnRNPK binding to its 3′ UTR [PMID:16366736, PMID:35899624, PMID:16845607, PMID:15485813]. Through its control of mitochondrial ROS, UCP2 regulates AMPK–FoxO1 and HIF-1α signaling, macrophage inflammatory activation, microglial synapse elimination, pancreatic alpha-cell glucagon secretion, stem-cell metabolic transitions, and susceptibility to tumorigenesis [PMID:35899624, PMID:18006654, PMID:33879866, PMID:23434936, PMID:22085932, PMID:31461648].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that UCP2 possesses regulatable proton transport activity resolved whether this UCP1 homolog was itself a functional transporter; retinoids were identified as novel activators and nucleotides as inhibitors, defining UCP2's pharmacological profile.\",\n      \"evidence\": \"Proton transport assay in yeast mitochondria expressing recombinant UCP2, compared with UCP1 and UCP3\",\n      \"pmids\": [\"10545094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether retinoid activation is physiologically relevant in vivo remained untested\", \"Molecular mechanism of retinoid-mediated activation unresolved\", \"Transport substrate identity beyond protons was unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying translational control mechanisms for UCP2 explained how UCP2 protein levels can be rapidly tuned independently of mRNA: a 5′-UTR uORF suppresses translation, and hnRNPK binding to the 3′ UTR promotes translation on polysome-coated mitochondria.\",\n      \"evidence\": \"Reporter constructs with uORF mutations plus in vitro translation; yeast three-hybrid identification of hnRNPK, polysome fractionation, Western blot quantification\",\n      \"pmids\": [\"16845607\", \"15485813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological signals that relieve uORF-mediated repression were unidentified\", \"Whether hnRNPK-dependent regulation operates in non-insulin-responsive cells was unknown\", \"Structural basis of uORF-ribosome interaction not determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that SIRT1 directly represses UCP2 transcription in beta cells linked nutrient sensing to mitochondrial uncoupling and insulin secretion, establishing UCP2 as a physiological brake on glucose-stimulated insulin secretion.\",\n      \"evidence\": \"ChIP showing SIRT1 binding to UCP2 promoter, siRNA rescue of insulin secretion in SIRT1-deficient cells, SIRT1 knockout mice\",\n      \"pmids\": [\"16366736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIRT1-UCP2 axis operates in non-beta-cell contexts was unclear\", \"Identity of histone marks modified by SIRT1 at the UCP2 locus not characterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"UCP2 knockout studies in macrophages and islet alpha cells established that UCP2 controls cell-type-specific functions through ROS modulation: UCP2 loss increases macrophage inflammatory cytokine production via MAPK and impairs alpha-cell glucagon secretion by disrupting stimulus-secretion coupling.\",\n      \"evidence\": \"UCP2 KO mice with macrophage cytokine/NO assays, insulitis scoring; alpha-cell ATP/O ratios, glucagon secretion, mitochondrial membrane potential; conditional alpha-cell KO with ROS rescue\",\n      \"pmids\": [\"18006654\", \"18701716\", \"23434936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ROS species mediating effects are superoxide vs. H2O2 was not distinguished\", \"Direct ROS targets in alpha-cell secretory machinery unidentified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing that ghrelin-mediated neuroprotection of dopamine neurons requires UCP2 established UCP2 as a downstream effector of neuropeptide signaling in the CNS, linking mitochondrial uncoupling to neuronal survival.\",\n      \"evidence\": \"Genetic epistasis using GHSR KO mice with selective catecholaminergic reactivation, MPTP neurotoxin model, UCP2-dependent mitochondrial respiration and ROS measurements\",\n      \"pmids\": [\"19906954\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UCP2 induction by ghrelin is transcriptional or translational was unclear\", \"Applicability to human neurodegenerative disease not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that UCP2 prevents mitochondrial glucose oxidation in stem cells and is required for the glycolysis-to-OXPHOS metabolic transition during differentiation revealed UCP2 as a metabolic gatekeeper of cell fate decisions.\",\n      \"evidence\": \"siRNA knockdown and ectopic overexpression in human pluripotent stem cells, oxygen consumption and metabolic flux assays, differentiation assays\",\n      \"pmids\": [\"22085932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which UCP2 is downregulated during differentiation not established\", \"Whether substrate shunting or proton leak drives the stem cell effect was unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Post-translational regulation of UCP2 by glutathionylation was shown to deactivate proton leak, establishing redox-sensitive control of UCP2 activity with implications for chemoresistance in leukemia cells.\",\n      \"evidence\": \"Diamide-induced glutathionylation with proton leak respiration assay and UCP2 knockdown in drug-resistant leukemia cells\",\n      \"pmids\": [\"23069211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific cysteine residues targeted by glutathionylation not mapped\", \"Whether glutathionylation also regulates the metabolite transport function was untested\", \"No independent replication in other cell types\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The landmark reconstitution of UCP2 in lipid vesicles redefined its primary molecular function: UCP2 is a C4 metabolite/phosphate exchanger rather than a protonophore, explaining its ability to limit glucose oxidation by exporting oxaloacetate, malate, and aspartate from the mitochondrial matrix.\",\n      \"evidence\": \"Direct transport assay of reconstituted UCP2 in lipid vesicles; metabolomics and bioenergetic validation in UCP2-silenced HepG2 cells\",\n      \"pmids\": [\"24395786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for C4 substrate selectivity unknown\", \"How proton leak and metabolite transport activities are related mechanistically was unresolved\", \"In vivo confirmation of transport specificity lacking\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple studies established UCP2 as a signaling hub linking metabolic substrate routing to downstream kinase pathways: UCP2 modulates FABP4-dependent NLRP3 inflammasome activation in macrophages, ROS-AKT signaling in pancreas development, and AKT-PFKFB2 glycolytic flux in skin cells.\",\n      \"evidence\": \"FABP4 KO with UCP2 siRNA rescue and inflammasome assays; Ucp2 KO mice with pancreas morphometry and NAC rescue; UCP2 overexpression with AKT/PFKFB2 pathway inhibitor experiments\",\n      \"pmids\": [\"27795298\", \"29079704\", \"29221144\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ROS-AKT and FABP4-UCP2 axes converge on common effectors was unclear\", \"Relative contributions of metabolite transport vs. uncoupling to these signaling effects not dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Cell-type-specific conditional knockouts revealed UCP2's roles in microglial biology: UCP2 mediates HFD-induced mitochondrial dynamic changes and hypothalamic inflammation controlling energy balance, and regulates microglial synapse phagocytosis in hippocampus affecting anxiety behavior.\",\n      \"evidence\": \"Conditional microglial Ucp2 KO with mitochondrial dynamics imaging, POMC neuron activation analysis, synapse phagocytosis confocal imaging, electrophysiology, and behavioral testing\",\n      \"pmids\": [\"31495690\", \"33879866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between UCP2-dependent ROS and phagocytic machinery not identified\", \"Whether UCP2's metabolite transport or uncoupling function drives microglial effects is unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"UCP2's C4 metabolite transport function was validated in cancer metabolism: UCP2-mediated aspartate efflux fuels cytosolic NADPH production via glutaminolysis in KRAS-mutant pancreatic cancer, and UCP2 loss increases colon tumorigenesis by depleting NADPH and promoting phospholipid synthesis.\",\n      \"evidence\": \"UCP2 siRNA in KRAS-mutant PDAC cells with metabolic flux, NADPH/NADP+ ratio, xenograft models; UCP2 KO in AOM/DSS and ApcMin/+ colon cancer models with metabolomics\",\n      \"pmids\": [\"33230296\", \"31461648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether UCP2 transport activity is druggable in cancer contexts is untested\", \"Tissue-specific opposing roles (tumor-promoting vs. tumor-suppressive) not mechanistically reconciled\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of KLF2 as a shear-stress-responsive transcription factor that directly activates UCP2 in endothelial cells connected UCP2 to vascular mechanotransduction; UCP2 suppresses endothelial inflammation through AMPK-FoxO1 signaling and protects against atherosclerosis.\",\n      \"evidence\": \"ChIP for KLF2 binding to UCP2 promoter, EC-specific Ucp2 KO and AAV overexpression in vivo, RNA-seq, AMPK/FoxO1 pathway analysis\",\n      \"pmids\": [\"35899624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How UCP2 activates AMPK—through metabolite transport, ROS, or AMP/ATP ratio—is not resolved\", \"Whether other shear-responsive transcription factors co-regulate UCP2 is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"UCP2 was shown to act as a metabolic oxygen sensor in cardiomyocytes, controlling acetyl-CoA levels and histone acetylation under hypoxia, linking UCP2's metabolite transport to epigenetic regulation of cell cycle activity.\",\n      \"evidence\": \"UCP2 global KO mice under hypoxia with acetyl-CoA measurement, histone acetylation assay, DNA damage markers, cardiomyocyte cell cycle analysis\",\n      \"pmids\": [\"35771638\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which UCP2 senses oxygen not determined\", \"Whether acetyl-CoA changes reflect altered transport or altered TCA flux is unclear\", \"Not confirmed with conditional cardiomyocyte-specific KO\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified structural and biophysical model reconciling UCP2's dual activities—C4 metabolite transport and regulatable proton conductance—is lacking, and the relative contribution of each activity to UCP2's diverse cell-type-specific phenotypes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of UCP2 in a transport-competent state with bound substrate\", \"Cell-type-specific conditional studies have not systematically separated metabolite transport from uncoupling\", \"Druggability of UCP2 transport function is unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 5, 6, 28]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 5, 8, 14, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 5, 6, 16, 21, 28]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [7, 10, 15, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 20, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SIRT1\",\n      \"KLF2\",\n      \"HNRNPK\",\n      \"FABP4\",\n      \"SIRT3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}